TY - JOUR
T1 - Androgen metabolites impact CSF amines and axonal serotonin via MAO-A and -B in male macaques
AU - Bethea, C. L.
AU - Phu, K.
AU - Kim, A.
AU - Reddy, A. P.
N1 - Funding Information:
We are very grateful to Kevin Muller for training, administering drugs and monitoring the health and wellbeing of the animals. We greatly appreciate Dr. Kris Coleman and Nicola Robertson for earlier behavioral observations and analysis. We thank the Primate Genetics Program at the Oregon National Primate Research Center for calculations of the relatedness of our animals. We are also grateful to Dr. Jay Welch and the technicians of the Division of Comparative Medicine (DCM), for the management and care of our animals. We thank the Surgery and Pathology Sections of DCM for their expertise and handling of our needed surgeries and necropsies. This work was funded by NIH MH86542 and P51 OD11092 .
Funding Information:
This study was funded by NIH grants MH86542 to CLB and P51 OD11092 for support of the Oregon National Primate Research Center.
Publisher Copyright:
© 2015 IBRO.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - A number of studies have shown that mutations or deletions of the monoamine oxidase-A (MAO-A) gene cause elevated CNS serotonin and elevated impulsive aggression in humans and animal models. In addition, low cerebrospinal fluid (CSF) 5-hydroxyindole acetic acid (5HIAA) has been documented in a limited number of violent criminal populations and in macaques that exhibit impulsive aggression. To reconcile these different analyses, we hypothesized that CSF 5HIAA reflected degradation of serotonin by the activity of MAO-A; and that low MAO-A activity would result in lower CSF 5HIAA, but overall higher serotonin in the CNS. To test this hypothesis, male Japanese macaques (Macaca fuscata) were castrated, rested for 5-7months, and then treated for 3months with [1] placebo, [2] testosterone (T), [3] dihydrotestosterone (DHT; non-aromatizable androgen) and 1,4,6-androstatriene-3,17-dione (ATD) (steroidal aromatase inhibitor), or [4] flutamide (FLUT; androgen antagonist) and ATD (n=5/group). These treatments enable isolation of androgen and estrogen activities. In the dorsal raphe, MAO-A and MAO-B expressions were determined with in situ hybridization (ISH) and protein expression of aromatase was determined with immunohistochemistry (IHC). CSF concentrations of 5HIAA, 3-methoxy-4-hydroxyphenylglycol (MHPG), and homovanillic acid (HVA) were determined with liquid chromatography/mass spectrometry (LC/MS). From the same animals, previously published data on serotonin axon density were used as a proxy for CNS serotonin. Aromatase conversion of T to estrogen (E) suppressed MAO-A (positive pixel area, p=0.0045), but androgens increased MAO-B (positive pixel area, p=0.014). CSF 5HIAA was suppressed by conversion of T to E (Cohen's d=0.6). CSF 5HIAA was positively correlated with MAO-A-positive pixel area (r2=0.78). CSF 5HIAA was inversely correlated with serotonin axon-positive pixel area (r2=0.69). In summary, CSF 5HIAA reflects MAO-A activity rather than global serotonin. Low CSF 5HIAA may, in this paradigm, reflect higher serotonin activity. Androgens lower MAO-A activity via metabolism to E, thus elevating CNS serotonin and decreasing CSF 5HIAA. Since androgens increase certain types of aggression, these data are consistent with studies demonstrating that lower MAO-A activity is associated with elevated serotonin and increased aggression.
AB - A number of studies have shown that mutations or deletions of the monoamine oxidase-A (MAO-A) gene cause elevated CNS serotonin and elevated impulsive aggression in humans and animal models. In addition, low cerebrospinal fluid (CSF) 5-hydroxyindole acetic acid (5HIAA) has been documented in a limited number of violent criminal populations and in macaques that exhibit impulsive aggression. To reconcile these different analyses, we hypothesized that CSF 5HIAA reflected degradation of serotonin by the activity of MAO-A; and that low MAO-A activity would result in lower CSF 5HIAA, but overall higher serotonin in the CNS. To test this hypothesis, male Japanese macaques (Macaca fuscata) were castrated, rested for 5-7months, and then treated for 3months with [1] placebo, [2] testosterone (T), [3] dihydrotestosterone (DHT; non-aromatizable androgen) and 1,4,6-androstatriene-3,17-dione (ATD) (steroidal aromatase inhibitor), or [4] flutamide (FLUT; androgen antagonist) and ATD (n=5/group). These treatments enable isolation of androgen and estrogen activities. In the dorsal raphe, MAO-A and MAO-B expressions were determined with in situ hybridization (ISH) and protein expression of aromatase was determined with immunohistochemistry (IHC). CSF concentrations of 5HIAA, 3-methoxy-4-hydroxyphenylglycol (MHPG), and homovanillic acid (HVA) were determined with liquid chromatography/mass spectrometry (LC/MS). From the same animals, previously published data on serotonin axon density were used as a proxy for CNS serotonin. Aromatase conversion of T to estrogen (E) suppressed MAO-A (positive pixel area, p=0.0045), but androgens increased MAO-B (positive pixel area, p=0.014). CSF 5HIAA was suppressed by conversion of T to E (Cohen's d=0.6). CSF 5HIAA was positively correlated with MAO-A-positive pixel area (r2=0.78). CSF 5HIAA was inversely correlated with serotonin axon-positive pixel area (r2=0.69). In summary, CSF 5HIAA reflects MAO-A activity rather than global serotonin. Low CSF 5HIAA may, in this paradigm, reflect higher serotonin activity. Androgens lower MAO-A activity via metabolism to E, thus elevating CNS serotonin and decreasing CSF 5HIAA. Since androgens increase certain types of aggression, these data are consistent with studies demonstrating that lower MAO-A activity is associated with elevated serotonin and increased aggression.
KW - Aromatase
KW - CSF 5HIAA
KW - MAO-A
KW - MAO-B
KW - Male
KW - Serotonin
UR - http://www.scopus.com/inward/record.url?scp=84936876226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936876226&partnerID=8YFLogxK
U2 - 10.1016/j.neuroscience.2015.06.020
DO - 10.1016/j.neuroscience.2015.06.020
M3 - Article
C2 - 26086546
AN - SCOPUS:84936876226
VL - 301
SP - 576
EP - 589
JO - Neuroscience
JF - Neuroscience
SN - 0306-4522
ER -